KR950031099A - Lactic acid bacteria-containing sakha drug composition - Google Patents

Lactic acid bacteria-containing sakha drug composition Download PDF

Info

Publication number
KR950031099A
KR950031099A KR1019950002954A KR19950002954A KR950031099A KR 950031099 A KR950031099 A KR 950031099A KR 1019950002954 A KR1019950002954 A KR 1019950002954A KR 19950002954 A KR19950002954 A KR 19950002954A KR 950031099 A KR950031099 A KR 950031099A
Authority
KR
South Korea
Prior art keywords
sakha
lactic acid
drug composition
acid bacteria
species
Prior art date
Application number
KR1019950002954A
Other languages
Korean (ko)
Other versions
KR100255887B1 (en
Inventor
유미 고바리
미사오 무라타
타다시 나리타
요우이치 나카지마
아키라 이와사
Original Assignee
타이도 나오카타
에스에스 세이야쿠 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 타이도 나오카타, 에스에스 세이야쿠 가부시키가이샤 filed Critical 타이도 나오카타
Publication of KR950031099A publication Critical patent/KR950031099A/en
Application granted granted Critical
Publication of KR100255887B1 publication Critical patent/KR100255887B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Display Devices Of Pinball Game Machines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

본 발명은 플랜타고 아바타종 껍질 및 유산균을 함유하는 사하약 조성물을 개시한다. 본 조성물은 장내 세균총의 밸런스를 정상상태로 유지하는 작용을 가지며, 심한 복통, 물 같은 변 및 연용에 의한 내성을 수반하지 않고 확실한 사하효과를 발휘한다.The present invention discloses a lower drug composition containing a plantago avatar shell and lactic acid bacteria. The composition has the effect of maintaining the balance of the intestinal flora in a normal state, and exhibits a certain dead-low effect without severe resistance to abdominal pain, watery stools and resistance.

Description

유산균 함유 사하약 조성물Lactic acid bacteria-containing sakha drug composition

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (3)

플랜타고 오바타종 껍질 및 유산균을 함유하는 사하약 조성물.Sakha drug composition containing a plantago obata species shell and lactic acid bacteria. 제1항에 있어서, 당류를 추가로 함유하는 것인 사하약 조성물.The composition according to claim 1, which further contains a saccharide. 제2항에 있어서, 플랜타고 오바타종 껍질과 당류가 플랜타고 오바타종 껍질 표면에 수계 용매 존재하에 당류를 부착시켜 얻어진 부정형 과랍화물로서 배합된 것인 사하약 조성물.The Sakha drug composition according to claim 2, wherein the plantago obata species shells and saccharides are formulated as an amorphous perlobate obtained by attaching the saccharides in the presence of an aqueous solvent on the surface of the plantago obata species shells. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950002954A 1994-03-03 1995-02-16 Laxative composition containing lactic acid bacterium KR100255887B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP6033344A JPH07242557A (en) 1994-03-03 1994-03-03 Evacuant composition containing lactic acid bacterium
JP33344/1994 1994-03-03

Publications (2)

Publication Number Publication Date
KR950031099A true KR950031099A (en) 1995-12-18
KR100255887B1 KR100255887B1 (en) 2000-05-01

Family

ID=12383956

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950002954A KR100255887B1 (en) 1994-03-03 1995-02-16 Laxative composition containing lactic acid bacterium

Country Status (2)

Country Link
JP (1) JPH07242557A (en)
KR (1) KR100255887B1 (en)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
KR20030069231A (en) * 2002-02-02 2003-08-27 비앤아이티(주) The improvement product of intestianl function by means of constipation type
WO2005099821A1 (en) * 2004-04-13 2005-10-27 Boehringer Ingelheim International Gmbh Use of simethicone in constipated patients
JP2008120719A (en) * 2006-11-10 2008-05-29 Sato Pharmaceutical Co Ltd Purgative
RU2013109251A (en) 2010-08-04 2014-09-10 Томас Джулиус БОРОДИ COMPOSITIONS FOR TRANSPLANTATION OF FEKAL FLORA AND METHODS FOR THEIR RECEIVING AND APPLICATION AND DEVICES FOR THEIR DELIVERY
CN103561752B (en) 2011-03-09 2016-04-20 明尼苏达大学评议会 For transplanting compositions and the method for faecal flora group
US9719144B2 (en) 2012-05-25 2017-08-01 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
CN104383334A (en) * 2014-11-30 2015-03-04 薛学明 Medicine for cleaning intestinal toxins and preparation method of medicine
WO2016183577A1 (en) 2015-05-14 2016-11-17 Crestovo Llc Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them
BR112017024777A2 (en) 2015-05-22 2018-08-07 Univ Arizona State use of a pharmaceutical composition and a non-absorbable antibiotic for treating autistic spectrum disorder cross reference to related applications?
CN105267839A (en) * 2015-10-27 2016-01-27 刘东兴 Suppository for treating constipation caused by dyspepsia and preparation method of suppository
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
AU2018250206A1 (en) 2017-04-05 2019-10-31 Crestovo Holdings Llc Compositions and methods for treating parkinson's disease (PD) and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
CN110996917A (en) 2017-05-26 2020-04-10 克雷斯顿沃控股公司 Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods of making and using same
AU2018313766A1 (en) 2017-08-07 2020-02-20 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
AU2019351017A1 (en) 2018-09-27 2021-04-29 Finch Therapeutics Holdings Llc. Compositions and methods for treating epilepsy and related disorders

Also Published As

Publication number Publication date
JPH07242557A (en) 1995-09-19
KR100255887B1 (en) 2000-05-01

Similar Documents

Publication Publication Date Title
KR950031099A (en) Lactic acid bacteria-containing sakha drug composition
KR890015742A (en) Topical preparations for the treatment of diseases
KR880008799A (en) Bath composition
ES2040240T3 (en) PLATINUM CYSTOSTATIC AGENT.
TR199701617T1 (en) An agent to be used to combat parasites in farm-produced fish.
KR880001222A (en) Animal Feed
KR840004361A (en) Plant extracts of the family "Hypoxidesi" (Hypoxidaceae) for the treatment of cancer
KR920701418A (en) How to prepare yeast extract
BRPI0413838A (en) antimicrobial aryloxazolidinone compounds
KR910000115A (en) External preparation to inhibit melanin production
KR870007667A (en) Prevention of Rice Cake Decay
KR940010989A (en) Hair-grown and woolen agents containing orthomethoxycinnamate
KR960013242A (en) Healthy salt composition containing chitosan and roasted salt
KR960020978A (en) Cosmetic Cream Composition
RU2001113082A (en) Composition for the manufacture of dragees
KR920004284A (en) Method for preparing microbial nutritional composition for wastewater treatment
DE69815153D1 (en) SYNERGISTIC ANTIMICROBIAL COMPOSITIONS
KR970014586A (en) Bioactive Agents in Fish, Feed Additives for Fish Farming
KR960036930A (en) Crustacean Food and Food Additives
KR910009917A (en) Antitumor Drugs Using Lactic Acid Bacteria
ES2140339A1 (en) Use of streptothricins B and F, which are natural fungicides for controlling phytopathogens in banana trees and plantains
KR920007538A (en) Herbicidal compositions based on benfuresate and dimelone
KR960006929A (en) A drug for the treatment of thyroid disease using the extract of Zom tobacco extract as an active ingredient
KR970025598A (en) Oral liquid composition for removing bad breath
KR930013016A (en) Antibacterial Emulsion Synthetic Resin Composition

Legal Events

Date Code Title Description
A201 Request for examination
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee